The task force group reported a higher frequency of APS nephropathy in patients with positive aPL (p < 0.001) compared to those without aPL (Evidence Level II) and in primary APS compared to SLE-APS, and to SLE with positive aPL but without APS. Here, FASLG is linked to autoimmune polyendocrinopathy.